Communiqués IDEXX Laboratories, Inc. Sao Paulo

Actions

I1DX34

BRI1DXBDR001

Equipement, fournitures et distribution médicale

Marché Fermé - Sao Paulo 19:30:10 13/08/2026			Varia. 5j.	Varia. 1 janv.
578,89 ^BRL	-2,05%		-5,40%	-23,36%

11/08	IDEXX Laboratories lance le test Catalyst proBNP pour l'évaluation des maladies cardiaques en clinique	MT
11/08	IDEXX Laboratories, Inc. : Barclays persiste à l'achat	ZM

Communiqués

11/08	IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test	BU
05/08	IDEXX Laboratories : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
04/08	IDEXX Laboratories : Earnings snapshot Q2 2026	PU
04/08	Idexx: Q2 Earnings Snapshot	AQ
04/08	IDEXX Laboratories Announces Second Quarter Results	BU
28/07	IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals	BU
01/07	IDEXX Laboratories to Release 2026 Second Quarter Financial Results	BU
26/05	IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection	BU
19/05	IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles	BU
14/05	IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day	BU
06/05	IDEXX Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05/05	IDEXX Laboratories : Earnings snapshot Q1 2026	PU
05/05	Idexx: Q1 Earnings Snapshot	AQ
05/05	IDEXX Laboratories Announces First Quarter Results	BU
05/05	Diagnostics, Vet Visits, Giving Pets a Voice: Jay Mazelsky & Jay Price	AQ
08/04	IDEXX Laboratories to Release 2026 First Quarter Financial Results	BU
01/04	IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma	BU
02/03	IDEXX Laboratories : Raymond James Institutional Investors Conference Presentation	PU
12/02	IDEXX Laboratories to Present at Two Institutional Investor Conferences	BU
02/02	IDEXX Laboratories : Prepared remarks FY 2025	PU
02/02	Idexx: Q4 Earnings Snapshot	AQ
02/02	IDEXX Laboratories : Earnings snapshot FY 2025	PU
02/02	IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results	BU
15/01	Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus	BU
15/01	IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs	BU